Genomics and epigenomics of clear cell renal cell carcinoma: Recent developments and potential applications
- 1 December 2013
- journal article
- review article
- Published by Elsevier BV in Cancer Letters
- Vol. 341 (2), 111-126
- https://doi.org/10.1016/j.canlet.2013.08.006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Clinical and Pathologic Impact of Select Chromatin-modulating Tumor Suppressors in Clear Cell Renal Cell CarcinomaEuropean Urology, 2013
- PARK2 and PACRG are commonly downregulated in clear‐cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcomeGenes, Chromosomes and Cancer, 2012
- Renal Cell Neoplasms Contain Shared Tumor Type–Specific Copy Number VariationsThe American Journal of Pathology, 2012
- Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patientsGenes, Chromosomes and Cancer, 2012
- Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney TumorCell, 2012
- Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor BiologyEuropean Urology, 2012
- CD31, EDNRB and TSPAN7 are promising prognostic markers in clear‐cell renal cell carcinoma revealed by genome‐wide expression analyses of primary tumors and metastasesInternational Journal of Cancer, 2011
- Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinomaGenes, Chromosomes and Cancer, 2011
- Genome‐wide profiling of chromosomal alterations in renal cell carcinoma using high‐density single nucleotide polymorphism arraysInternational Journal of Cancer, 2009
- HIF-α Effects on c-Myc Distinguish Two Subtypes of Sporadic VHL-Deficient Clear Cell Renal CarcinomaCancer Cell, 2008